A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane

Table 2

BCVA in both groups at baseline, one month, and three months.

BCVA (logMAR)		SCTA group (n = 13 eyes)	IVTA group (n = 10 eyes)	value
Baseline	Median (range)	1 (0.8–1)^a	1 (0.8–1.0)^a	0.927
1^st month	Median (range)	0.8 (0.7–0.9)^b	0.8 (0.7–0.9)^b	0.605
3^rd month	Median (range)	0.8 (0.6–0.9)^b	0.9 (0.8–0.9)^a,b	0.313
value		<0.001	0.003

The Mann–Whitney U test was used between groups. Within-group comparisons were done using Friedman’s test. Post hoc analysis was done using Bonferroni’s method, and different letters indicate a significant pair. BCVA, best-corrected visual acuity; SCTA, suprachoroidal triamcinolone acetonide; IVTA, intravitreal triamcinolone acetonide.